Correlation Between Vera Therapeutics and Intracellular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and Intracellular Th, you can compare the effects of market volatilities on Vera Therapeutics and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and Intracellular.

Diversification Opportunities for Vera Therapeutics and Intracellular

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vera and Intracellular is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and Intracellular go up and down completely randomly.

Pair Corralation between Vera Therapeutics and Intracellular

Given the investment horizon of 90 days Vera Therapeutics is expected to generate 2.36 times more return on investment than Intracellular. However, Vera Therapeutics is 2.36 times more volatile than Intracellular Th. It trades about 0.07 of its potential returns per unit of risk. Intracellular Th is currently generating about 0.05 per unit of risk. If you would invest  1,664  in Vera Therapeutics on August 27, 2024 and sell it today you would earn a total of  3,167  from holding Vera Therapeutics or generate 190.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vera Therapeutics  vs.  Intracellular Th

 Performance 
       Timeline  
Vera Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vera Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Vera Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Intracellular Th 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Vera Therapeutics and Intracellular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vera Therapeutics and Intracellular

The main advantage of trading using opposite Vera Therapeutics and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.
The idea behind Vera Therapeutics and Intracellular Th pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.